Content about Allegan, Michigan

July 27, 2011

Generic drug maker Perrigo has closed its purchase of Paddock Labs, the company said Tuesday.

ALLEGAN, Mich. — Generic drug maker Perrigo has closed its purchase of Paddock Labs, the company said Tuesday.

Perrigo acquired privately owned Paddock, a manufacturer of generic prescription and over-the-counter drugs based in Minneapolis, for $540 million.

“We are very pleased to welcome the Paddock team to the Perrigo family,” Perrigo chairman and CEO Joseph Papa said. “This acquisition is another important step forward in executing Perrigo’s strategy to expand our specialty portfolio of generic Rx products.”

June 30, 2011

Perrigo on Wednesday announced that its closing date to complete the acquisition of Paddock Labs — a generic pharmaceutical and specialty over-the-counter products manufacturer — has been delayed by an extended Federal Trade Commission review.

ALLEGAN, Mich. — Perrigo on Wednesday announced that its closing date to complete the acquisition of Paddock Labs — a generic pharmaceutical and specialty over-the-counter products manufacturer — has been delayed by an extended Federal Trade Commission review.

May 17, 2011

Perrigo on Monday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for over-the-counter ranitidine 150 (regular and cool mint), a generic version of Zantac 150.

ALLEGAN, Mich. — Perrigo on Monday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for over-the-counter ranitidine 150 (regular and cool mint), a generic version of Zantac 150.

Zantac 150 has annual sales of approximately $110 million, as measured by SymphonyIRI Group, Perrigo reported.

May 3, 2011

The Food and Drug Administration has approved a generic version of Rogaine made by Perrigo, the drug maker said.

ALLEGAN, Mich. — The Food and Drug Administration has approved a generic version of Rogaine made by Perrigo, the drug maker said.

Perrigo announced the FDA approval of over-the-counter minoxidil foam, a generic version of men’s Rogaine foam.

Stiefel Research Australia, part of GlaxoSmithKline, sued Perrigo for patent infringement when the latter submitted its regulatory approval application. Under a settlement between the companies reached in February, Perrigo can launch its generic version of men’s Rogaine foam in March 2012.

April 12, 2011

Perrigo on Tuesday announced that the Detroit office of the Food and Drug Administration has concluded its re-inspection of Perrigo's Allegan facility.

ALLEGAN, Mich. — Perrigo on Tuesday announced that the Detroit office of the Food and Drug Administration has concluded its re-inspection of Perrigo's Allegan facility.

The FDA has informed Perrigo that, effective immediately, Perrigo has an acceptable regulatory status, such that any pending export license and abbreviated new drug applications from this facility will once again be eligible for review and approval.

March 16, 2011

Perrigo on Wednesday named Tony Schott VP diabetes care for the consumer healthcare division.

ALLEGAN, Mich. — Perrigo on Wednesday named Tony Schott VP diabetes care for the consumer healthcare division.

In this role, Schott will expand Perrigo’s current distribution in retail store-brand glucose and grow sales and market share in this category.

March 2, 2011

Following the warning letter it received last April, Perrigo announced that the Food and Drug Administration has arrived at the company's Allegan, Mich.-based facility for re-inspection.

ALLEGAN, Mich. — Following the warning letter it received last April, Perrigo announced that the Food and Drug Administration has arrived at the company's Allegan, Mich.-based facility for re-inspection.

February 25, 2011

Perrigo on Friday named Lynden Johncock to the post of trade promotion manager with the sales department. In this combined marketing and sales role, Johncock will act as a liaison between customers and Perrigo to ensure effective exchange of ideas for business and product line growth.

ALLEGAN, Mich. — Perrigo on Friday named Lynden Johncock to the post of trade promotion manager with the sales department. In this combined marketing and sales role, Johncock will act as a liaison between customers and Perrigo to ensure effective exchange of ideas for business and product line growth.

February 17, 2011

Perrigo on Thursday announced that it has entered into an exclusive agreement with AgaMatrix to sell and distribute blood-glucose monitors and test strips in the U.S. store-brand channel.

ALLEGAN, Mich. — Perrigo on Thursday announced that it has entered into an exclusive agreement with AgaMatrix to sell and distribute blood-glucose monitors and test strips in the U.S. store-brand channel.

Nipro Diagnostics long has dominated store-brand blood-glucose meters with a co-branding program that includes TRUE2Go, TRUEresult and TRUEtrack.

As part of the agreement, Perrigo will sell and distribute certain products in the current AgaMatrix portfolio, as well as certain future new products.

Terms of the deal were not disclosed.

January 21, 2011

Perrigo will buy Paddock Labs for more than half a billion dollars, Perrigo said Thursday.

ALLEGAN, Mich. — Perrigo will buy Paddock Labs for more than half a billion dollars, Perrigo said Thursday.

Perrigo, an Allegan, Mich.-based company that makes generic prescription and over-the-counter drugs, including private-label products, announced that it would buy Minneapolis-based Paddock for $540 million in cash.

November 30, 2010

The Food and Drug Administration has granted market exclusivity for a generic version of a medication designed to treat indoor and outdoor allergies.

ALLEGAN, Mich. — The Food and Drug Administration has granted market exclusivity for a generic version of a medication designed to treat indoor and outdoor allergies.

Perrigo said Monday that its licensor and supplier Synthon received regulatory approval for levocetirizine tablets, a generic version of UCB/Sepracor's Xyzal, which is marketed in the United States by Sanofi-Aventis.

The levocetirizine tablet is the only approved generic product having a label containing all indications, Perrigo said.

November 29, 2010

Perrigo on Monday launched a store-brand version of Bayer Healthcare’s Aleve Liquid Gels, 220 mg.

ALLEGAN, Mich. — Perrigo on Monday launched a store-brand version of Bayer Healthcare’s Aleve Liquid Gels, 220 mg.

Aleve Liquid Gels generated annual sales of approximately $80 million, Perrigo stated, citing SymphonyIRI Group data.

"This approval is another example of Perrigo's commitment to bring new products to market,” stated Perrigo's chairman and CEO Joseph Papa. Perrigo noted that it is the first-to-market with a generic equivalent of the Aleve Liquid Gels.

October 14, 2010

Perrigo on Friday welcomed Ryan McLaughlin as an associate category manager on the company’s nutrition...

ALLEGAN, Mich. Perrigo on Friday welcomed Ryan McLaughlin as an associate category manager on the company’s nutrition business team. McLaughlin will work closely with the company’s customer business managers and the Perrigo South Carolina nutrition team to connect with store-brand-vitamin consumers, support customers and drive Perrigo’s nutrition business, the company stated.

 

McLaughlin joined Perrigo in December 2007 as a supervisor of the supply planning process, supporting both over-the-counter and nutrition products.

September 8, 2010

The Food and Drug Administration has approved a generic drug for treating skin diseases made...

ALLEGAN, Mich. The Food and Drug Administration has approved Perrigo's generic drug for treating skin diseases, the drug maker said Wednesday.

 

The FDA approved Perrigo’s imiquimod cream in the 5% strength. The drug is a generic version of Graceway Pharmaceuticals’ Aldara.

 

 

The drug is used to treat actinic keratoses on the face and scalp, superficial basal cell carcinoma and external genital and perianal warts in patients ages 12 years and older.

 

May 11, 2010

Perrigo on Tuesday announced that David Kneisl has joined Perrigo as a customer business manager...

May 3, 2010

Perrigo on Monday announced that it has closed the previously announced acquisition of PBM Holdings,...

March 22, 2010

Perrigo announced Tuesday that it has signed a definitive merger agreement to acquire a baby...

March 22, 2010

Perrigo's current human resources director will assume the role of SAP HCM HR program manager,...

March 16, 2010

Perrigo on Wednesday promoted Rachel Humphreys to manager of supplier quality management for its U.S....

March 14, 2010

Perrigo on Monday announced that it has begun shipping ketotifen fumarate ophthalmic solution, 0.025%, a...